← Open Payments lookup

SHELAGH LARSON: Open Payments

NPI 1215077219 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,303 in 21 payments from 11 companies in 2025. Trend: 2023 $15,548 · 2024 $2,809 · 2025 $9,303

Speaker / faculty: $4,180Speaker / faculty: $2,009Consulting: $1,784Food & beverage: $1,330
CompanyPaymentsAmount
Organon LLC7$4,225
Bayer Healthcare Pharmaceuticals Inc.3$3,903
Sumitomo Pharma America, Inc.3$220
Corcept Therapeutics1$127
ARS Pharmaceuticals Operations, Inc.1$126
Otsuka Pharmaceutical Development & Commercialization, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.1$121
Lilly USA, LLC1$119
SANOFI-AVENTIS U.S. LLC1$119
Novo Nordisk Inc1$111

Products named: NEXPLANON, Lynkuet, GEMTESA, Korlym, NEFFY, REXULTI, GATTEX, MOUNJARO.

Industry payments across TX — which companies pay providers there.